Answers are grounded in this paper and cite their sources.
OBJECTIVES: This cohort study examined the associations between HIV status with SARS-CoV-2 viral load and duration of infection in a setting with high antiretroviral therapy (ART) coverage. METHODS: COVID-19 patients enrolled from public health clinics in Gaborone, Botswana underwent weekly serial testing for SARS-CoV-2. RT-PCR cycle threshold (Ct) value was used as a proxy measure of viral load. Multiple linear regression and Cox proportional-hazards models were used to determine the associations between HIV with Ct and time to SARS-CoV-2 negativity, respectively. RESULTS: Of the 486 enrolled participants, 88.7% were vaccinated for COVID-19, and 26.1% were people living with HIV (PLWH) with a mean CD4+ T cell count of 715 cells/µL and 86.6% taking ARTs. Mean Ct values were similar across HIV and CD4+ T cell categories (P = 0.76). Time to negativity was similar for PLWH with CD4+ T cell count ≥500 cells/µL (adjusted hazard ratio [aHR] = 1.00; 95% confidence interval [CI] = 0.61, 1.64) and <500 cells/µL (aHR = 1.24; 95% CI: 0.88, 1.75) compared to people without HIV. CONCLUSIONS: In a setting with well-controlled HIV and high COVID-19 vaccine coverage, HIV status was not associated with SARS-CoV-2 viral load or infection duration.
No takes yet. Share an insight, caveat, or question.
Deb et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: